4basebio PLC is a dynamic life sciences company focused on advancing next-generation therapies through innovative synthetic DNA and RNA solutions. They specialize in the development, manufacturing, and supply of high-purity, GMP-grade DNA (specifically opDNA™ and oeDNA™) and RNA products crucial for gene therapies, gene vaccines, cell therapies, and mRNA applications. With a commitment to quality and scalability, 4basebio supports biotech and pharmaceutical companies from research through to commercialization, enabling the development of novel treatments for a range of diseases. Their proprietary enzymatic synthesis technology offers advantages in terms of speed, quality, and complexity over traditional plasmid-based methods.
The Cambridge headquarters serves as the central hub for corporate operations, strategic leadership, research and development oversight, and business development for 4basebio's global activities.
Located within a key UK biotech cluster, likely featuring modern laboratory and office spaces suited for advanced life sciences R&D and corporate functions.
The work culture is expected to be collaborative, innovative, and science-driven, fostering a dynamic environment for researchers and professionals dedicated to advancing gene and cell therapies.
Its strategic location in one of Europe's leading biotechnology ecosystems facilitates innovation, access to talent, partnerships, and collaboration with research institutions.
4basebio supports its global client base in the pharmaceutical and biotechnology sectors through its strategically located facilities in the UK (Cambridge), Germany (Heidelberg), and Spain (Granada). These sites enable research, development, manufacturing, and commercial supply of its advanced DNA and RNA products, serving markets across Europe, North America, and Asia-Pacific. Their global presence facilitates collaborations and ensures efficient delivery of solutions for gene therapies, vaccines, and diagnostics worldwide.
25 Norman Way, Over
Cambridge
Cambridgeshire
United Kingdom
Address: Waldhofer Str. 102, 69123 Heidelberg, Germany
Serves as a crucial operational and R&D hub in continental Europe, supporting the development and production of advanced DNA technologies and enzymes for the European and global markets.
Address: Parque Tecnológico de la Salud, Avicena 8, planta 2, oficina B20, 18016 Granada, Spain
A key manufacturing and R&D site, particularly for its proprietary enzymatic DNA synthesis technologies, expanding 4basebio's production capabilities and scientific expertise in Southern Europe.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 4basebio' leadership includes:
4basebio has been backed by several prominent investors over the years, including:
In the past 12 months, 4basebio has seen a key transition in its finance leadership, with the appointment of a new Chief Financial Officer, Claire Thomson, who replaced Marcus Karia.
Discover the tools 4basebio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
4basebio primarily uses the [first_name].[last_name]@4basebio.com email format for its employees. This is a common professional email structure.
[first_name].[last_name]@4basebio.com
Format
heikki.lanckriet@4basebio.com
Example
85%
Success rate
4basebio PLC / London Stock Exchange RNS • April 29, 2024
4basebio PLC reported its audited final results for 2023, highlighting progress in its DNA manufacturing capabilities, client acquisition, and strategic objectives. The company noted increased revenues (GBP £1.7 million) and continued investment in R&D and production scale-up for its synthetic DNA products....more
Proactive Investors / London Stock Exchange RNS • February 1, 2024
4basebio PLC announced the appointment of Claire Thomson as chief financial officer and company secretary, effective immediately. Thomson brings over 20 years of experience in finance roles within the life sciences and technology sectors, succeeding Marcus Karia....more
Sharecast / Proactive Investors • October 16, 2023
4basebio PLC signed a supply agreement with a US-based biotechnology company for its synthetic DNA product, opDNA™, to be used in the development of a novel multi-neoantigen cancer vaccine. This marks a significant commercial milestone and validation for 4basebio's technology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 4basebio, are just a search away.